The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Topic summary

Coming back to: What the published dose-response for semaglutide actually looks like above 2.4 mg

This is a generated summary. It shows the 5 most-liked posts from a topic of 28, in their original order, with the accepted answer included where one exists. It is a reading aid and it will miss nuance — the full topic is the record.
SC
s.cardosoTL217 Nov 2025#1

The question in the title: What the published dose-response for semaglutide actually looks like above 2.4 mg I will give what I have already checked below so nobody repeats it.

I would like to know what people here actually do about published dose-response for semaglutide, as distinct from what is usually recommended. Those have diverged in every other subject I have looked at closely.

Mine is below, with the reasoning, including the parts I am not confident about.

59 likes 8mo
AZ
an.zamoraTL2 Solution24 Jan 2026#7

Answering the question post #3 raises rather than the one it answers.

Injection site does not appear to matter much for semaglutide exposure. The published comparisons of abdomen, thigh and upper arm found differences small enough to be clinically unimportant, which is not true of every injectable.

10 likes 6mo
B
batchlogTL3Regular19 Feb 2026#10

Reporting rather than recommending, on published dose-response for semaglutide. What happened is above. Whether it should have is a different question and not one I am qualified to answer.

31 likes 5mo
P
preregisteredTL3Research methods14 Mar 2026#13

Narrowing post #12, because the general version has more than one answer.

On dose steps: the four-week interval in the pivotal programme was a trial design choice, and slower escalation was not studied. That means the evidence supports not going faster and says nothing at all about going slower.

32 likes 4mo
KC
k.chukwuTL224 May 2026#23

If someone has run published dose-response for semaglutide properly I would rather read that than my own reconstruction of it. Posting mine only because the thread has gone quiet.

30 likes 2mo

Read the full topic (28 posts)

Suggested topics

TopicParticipantsRepliesViewsActivity
Why semaglutide solutions can look faintly opalescent and when that matters
The question in the title: Why semaglutide solutions can look faintly opalescent and when that matters I will give what I have already checked below so nobody repeats it. A follow-up question about…
DNGPRSDTMG+73 79 2k 4mo
Revisiting: Is there a ceiling dose beyond which semaglutide stops adding benefit?
Revisiting: Is there a ceiling dose beyond which semaglutide stops adding benefit? — that is the question, and I have not found it answered plainly anywhere I have looked. Putting the numbers in the first…
AWBWCEPLEK+5 9 30k 8d
Semaglutide in people without diabetes: what the evidence base looks like
Semaglutide in people without diabetes: what the evidence base looks like Writing it up because I had to work it out twice and would rather nobody else did. What changes if the standard account of semaglutide…
GCSDNVMHN+2 6 18k 17mo
What SELECT changed about how semaglutide is discussed, and what it did not
Asking directly, because I could not find a straight answer: What SELECT changed about how semaglutide is discussed, and what it did not I was wrong about SELECT in a thread last spring and I would like to…
PFTVVDEMB+120 132 2k 14mo
Semaglutide half-life: where the 165 to 184 hour figure comes from
Semaglutide half-life: where the 165 to 184 hour figure comes from — setting out what I have, and where I think it stops being reliable. Putting the numbers in the first post, because a question about a…
KBDBVBNTIG+128 145 3k 4mo

Related topics — sharing the tags effect size, type 2 diabetes, semaglutide

TopicParticipantsRepliesViewsActivity
A 40-week log with the measurement method stated — does this still hold?
A 40-week log with the measurement method stated — does this still hold? I have a specific reason for asking rather than idle curiosity, and the context is below. Posting a small dataset on 40-week log. It is…
LGDTAVGPFY+1 5 14k 2mo
Stepping down deliberately, and how to do it without losing progress — what changed since
Posting this under the heading it deserves: Stepping down deliberately, and how to do it without losing progress — what changed since Everything below is what sits behind that. Something changed and I would…
BODTANABMS+94 99 29k 2d
The most common factual error about semaglutide on the internet — what changed since
The most common factual error about semaglutide on the internet — what changed since — setting out what I have, and where I think it stops being reliable. Putting the numbers in the first post, because a…
SKBOSBBDAL+42 46 1.7k 5mo
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile
Posting this under the heading it deserves: Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Everything below is what sits behind that. Semaglutide and gastric emptying,…
DEIBHMMMCN+115 122 2.6k 1d
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one I have a specific reason for asking rather than idle curiosity, and the context is below. A methods question rather than a…
CCMDBWGRAZ+130 135 11k 7mo